The CLIA regulations..

Similar documents
Karen W. Dyer MT(ASCP), DLM Director, Division of Laboratory Services Centers for Medicare & Medicaid Services CLIA

Daralyn Hassan, MS, MT(ASCP) April 3rd, 2014 CLIA

Point of Care Testing


A COLA White Paper: FEDERAL GOVERNMENT QUESTIONS QUALITY IN WAIVED TESTING.

TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES

POINT OF CARE TESTING MED Laboratory Branch Kim DeGroat, RMLS - Frankfurt Region Wilfred Lovelock, RMLS - Dakar Region

Rapid Specimen Testing In the Medical Office (POCT)

PROGRAM GUIDE - UNIVERSITY CLIA REGISTERED LABORATORIES COMPLIANCE COMMITTEE

CAP Most Frequent Deficiencies and How to Avoid Them. March 11, 2015

Quality Assurance Program For Hospital Based Point of Care Testing. Presented by: Jeanne Mumford, MT(ASCP) Pathology Supervisor, QA Specialist

Internal Lab Inspections: Are You Inspection Ready? Presented by: Jeanne Mumford, MT(ASCP) Manager, Point of Care Testing, JHM

Medicare Program; Announcement of the Reapproval of the Joint Commission as an

Point of Care Testing. BOPCC May 31, 2011 Beatrice O Keefe, Chief Laboratory Field Services California Department of Public Health

3/14/2016. The Joint Commission and IQCP. Objectives. Before Getting Started

Subject: Quality Management for Origin date: 3/06 Point of Care and Waived Testing Reviewed: 2009 /2010 Revised: 2/2009

Laboratory Risk Assessment: IQCP and Beyond. Ron S. Quicho, MS Associate Project Director Standards and Survey Methods, Laboratory July 18, 2017

CLIA & Individualized Quality Control Plan (IQCP) Karen W. Dyer MT(ASCP), DLM Director (Acting) Division of Laboratory Services

Catholic Health Initiatives

EDUCATIONAL COMMENTARY KEY COMPONENTS OF AN INDIVIDUALIZED QUALITY CONTROL PLAN

COMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program TEAM LEADER ASSESSMENT OF DIRECTOR & QUALITY CHECKLIST

Medicare Program; Announcement of the Approval of the American Association for

TITLE: POINT OF CARE TESTING

CLIA & Individualized Quality Control Plan (IQCP) Judith Yost Director Division of Laboratory Services

IQCP. Ensuring Your Laboratory s Compliance With Individualized Quality Control Plans. November/December 2016

PERSONNEL REQUIREMENTS. March 9, 2018

Tutorial: Basic California State Laboratory Law

Primary Ingredients. Primary Ingredients. Referrals. Positive cash-flow. Dedication & growth Give it some time and put effort into it

Centers for Medicare and Medicaid Services (CMS) Survey and Certification Group (SCG) Mission:

C A L I F O R N I A L A B O R AT O RY P E R S O N N E L

Center for Medicaid and State Operations/Survey and Certification Group

Policy Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail MISSION STATEMENT: OVERVIEW:

Individualized Quality Control Plan (IQCP) Frequently Asked Questions Date: May 5, 2015 (last updated 08/21/2017)

Standards for Laboratory Accreditation

CE Update [generalist compliance/regulation management/administration and training] COLA Accreditation An Educational Experience

Request for Information: Revisions to Personnel Regulations, Proficiency Testing

CLIA S NEW IQCP SEABB. March 19, Linda Sigg, MT(ASCP)SBB,CQA(ASQ) Staff Lead Assessor, Accreditation, AABB

Point of Care Quality Management. Procedure. Approving Authority: President and CEO, Keith Dewar

Learning Objectives. Individualized Quality Control Plans. Agenda. Another Way To Determine QC? Hooray!!!! What is QC?

CAP Forensic Drug Testing Accreditation Program Standards for Accreditation

CLIA s New IQCP Requirements Are in Effect, or Are They?: Implementing Laboratory Risk Management Now to Ensure Success

A Review and Analysis of the Clinical Laboratory Improvement Amendment of 1988: Compliance Plans and Enforcement Policy

CCT Exam Study Manual Update for 2018

Performance of Point-of-Care Testing in Unaccredited Settings:

STANDARDS Point-of-Care Testing

ASSEMBLY BILL No. 940

Standards for Forensic Drug Testing Accreditation

Master. Point-of-Care-Testing Checklist. CAP Accreditation Program

Improving Your POC Program: An Upside Down Map. Sheila K. Coffman MT(ASCP)

CLIA Regulations Update 2015

1). AB-2436 Clinical laboratory testing.( )

Personnel. From RLM, COM, GEN and TLC Checklists

Heart of America POC Group Quality Management Making it Meaningful

CHALLENGES IN POCT. Dr. Jayesh P. Warade. Consultant Biochemistry and Quality Manager, Meenakshi Mission Hospital and Research Centre, Madurai, India

Plan for Quality to Improve Patient Safety at the POC

QC Explained Quality Control for Point of Care Testing

CAP Accreditation and Checklists Update. Lyn Wielgos, MT(ASCP) Checklist Editor, CAP Accreditation Programs

5/8/2015. Individualized Quality Control Plans (IQCP) Changes to the CMS Quality Requirements. CLIA Quality Control Evolution of the Process

Master. Point-of-Care-Testing Checklist. CAP Accreditation Program

How to Improve the Laboratory Experience CLS and MLT Working Together

What s New in Point-of-Care Testing (POCT)? Marjorie W. Doty, MT(ASCP)SBB OneBlood, Inc. St. Petersburg, FL

CLINICAL LABORATORY IMPROVEMENT AMENDMENTS OF 1988: HOW TO ASSURE QUALITY LABORATORY SERVICES

Laboratory Services Policy, Professional

CHAPTER 38 REGULATORY GUIDELINES IN THE MEDICAL LABORATORY

Topic: CAP s Legislative Proposal for Laboratory-Developed Tests (LDT) Date: September 14, 2015

COLA CATALOG WE GIVE YOU THE TOOLS TO SUCCEED RESOURCES FOR LABORATORY PERSONNEL EDUCATIONAL COURSES, PROGRAMS, AND MATERIALS

6/28/2016. Questions? Workshop 6 CAP Inspection Preparation Thursday, June 23, 2016

SUCCESSION PLANNING: FILLING A LABORATORY DIRECTOR S SHOES PART ONE

QC for the Future: Laboratory Issues POCT and POL concerns

Master. Point-of-Care-Testing Checklist. Every patient deserves the GOLD STANDARD... CAP Accreditation Program

C H A P T E R HAZARD ANALYSIS

Point of Care Testing Clinical Practice Standard and Policy (LTR31449) Version: 2.01

Fulton County Medical Center. Position Description. Pathologist, Laboratory Manager, and Medical Technologist

Regulatory,Quality & Emergency Preparedness. MaryBeth Parache Director, Quality Affairs New York Blood Center

IQCP January Is Coming Fast What Do I Do?!? Jean Ball Bold, MBA, MT(HHS), MLT(ASCP

15. Legal and Regulatory Issues. 1. Laws governing medicine and medical ethics complement and overlap each other.

What s New and Improved for the Laboratory Program in 2013 April 23, 2013

POCT Testing and Importance of Operator Lockout

Nestor A.Guerrero,BSMT,RMT,CLS,MT(ASCP) Major (Ret), US Army Medical Service Corps

US ): [42CFR ]:

College of Physicians and Surgeons of Saskatchewan Laboratory Quality Assurance Program. Policy Manual Edition

The CLSI Consensus Process: Making a Difference in Health Care David Sterry, MT(ASCP) Director, Standards Development, CLSI

Carter Healthcare, Inc

POINT OF CARE TESTING POLICY Page 1 of 6 Reviewed: October 2017

THE VALUE OF CAP S Q-PROBES & Q-TRACKS

Massachusetts General Hospital Point of Care Testing Program

The Ins and Outs of Point-of- Care Testing

The CAP Inspection Process

Standards, Guidelines, and Regulations

insights COLA Updates Into MAY / JUNE 12 COLA s

Medicare and Medicaid Program; Application from DNV GL Healthcare (DNV. GL) for Continued Approval of its Hospital Accreditation Program

National Association of Rural Health Clinics

THE MICROSCOOP SPRING-SUMMER EDITION 2017 VOLUME 34 NO. 1 OREGON STATE SOCIETY OF AMERICAN MEDICAL TECHNOLOGISTS

RHC COMPLIANCE AND REGULATIONS

AMERICAN BOARD OF HISTOCOMPATIBILITY AND IMMUNOGENETICS Laboratory Director. Content Outline

NZQA course. Perform urine drug screening in the workplace. UNIT STANDARD: US Urine drug screening in the workplace. Standard setting body (SSB)

Technical Job Family: Technician Progression

Laboratory Services INDIANA HEALTH COVERAGE PROGRAMS. Copyright 2017 DXC Technology Company. All rights reserved.

Life Cycle of A New Point of Care Test Request. Managing the Chaos

4/7/15. ASC Regulatory Update and Survey Trends. Objectives. Disclosure. Describe recent changes to the CMS interpretive guidelines.

Transcription:

Julia H. Appleton MT(ASCP), MBA Centers for Medicare & Medicaid Services (CMS) Center for Clinical Standards and Quality (CCSQ) Division of Laboratory Services (DLS) April 13, 2017

Objectives Explain an overview of Outline guidance on regulations; test complexity Describe Top Five deficiencies found in CW laboratories Analyze challenges for POCT Programs Discuss off-label Testing

What is? Clinical Laboratory Improvement Amendments Federal program that establishes quality laboratory standards to protect patient safety and improve health care

The regulations.. Established uniform quality standards for all laboratory testing to ensure accuracy, reliability and timeliness of patient test results regardless of where the test was performed.

Program Responsibilities CMS Clinical Laboratory Oversight CDC Scientific Consultation FDA Test Categorization

Tri-agency Responsibilities CMS, FDA and CDC have very distinct and complementary responsibilities CMS provides regulatory oversight and ensures that laboratories provide accurate, reliable and timely testing.

Tri-agency Responsibilities FDA has authority to implement the test complexity categorization which includes which tests are waived vs. nonwaived. CDC provides the education, scientific and research branch of the Tri-Agency

493.2 Definition of Laboratory Any facility that examines human specimens for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings

All clinical laboratories.. that perform testing on patient specimens must: apply for a certificate pay appropriate fees and follow applicable requirements

Waived Test Complexity Moderate complexity including the subcategory of Provider Performed Microscopy (PPM) High complexity Laboratories are certified at the highest level of testing performed

Certificate Types Certificate of Compliance (COC) Certificate of Accreditation (COA) Certificate for PPM (PPM) Certificate of Waiver (CoW)

Point-of-Care Testing (POCT) does not have a category for POCT. POCT are typically performed at the patient s bedside and/or outside the walls of a traditional lab. Depending on the facility, a POCT program can include complexity levels.. Waived Nonwaived Moderate and/or High complexity focuses on test complexity

Current Enrollment Statistics Total Number of Laboratories: 245,977 Compliance Labs: 18,157 Accredited Labs: 16,365 Waived Labs: 177,972 PPM Labs: 33,483 January 2017

Current Enrollment Statistics As of 01/2012 As of 01/2017 % change Total Number of Laboratories (NE) 229,815 245,977 7% Compliance Labs 19,387 18,157-6% Accredited Labs 15,697 16,365 4% Waived Labs 150,256 177,972 21% PPM Labs 37,559 33,483-11%

Waived Tests Simple laboratory examinations and procedures Cleared by FDA for home use; Employ methodologies that are so simple and accurate as to render the likelihood of erroneous results negligible; or Pose no reasonable risk of harm to the patient if the test is performed incorrectly.

Waived Testing regulations 493.15 Laboratories performing waived tests 493.15(e) Laboratories eligible for a certificate of waiver must- (1) Follow manufacturers instructions for performing the test; and (2) Meet the requirements in subpart B, Certificate of Waiver, of this part

Certificate of Waiver (CoW) Enroll in the program & pay fees Only perform tests categorized as waived Not subject to routine inspections Must follow manufacturer s instructions

CoW Personnel Requirements Must have a Laboratory Director There are no educational and experiential requirements for LD There are no other personnel requirements.

Nonwaived Tests Includes moderate and high complexity tests Must follow: All manufacturer s instructions and Applicable requirements AO requirements State requirements (ex. Maryland, New York) When in doubt, always follow the most stringent requirements

Nonwaived Tests More complex tests require more stringent requirements Subpart H - Proficiency Testing (PT) Subpart J Facility Administration

Subpart K Nonwaived Tests General Laboratory Preanalytical Analytical Postanalytical Quality Assessment (QA)Required

Nonwaived Testing Must perform the appropriate quality control as defined by the manufacturer, or the AO (whichever is the most stringent) Subpart M - Personnel qualifications and responsibilities for ALL personnel Qualified / Experienced Trained / Competent Accurate / Proficiently Compliant with regulations

POCT Programs POCT programs may incorporate different levels of test complexity. Operational structure of healthcare facilities can vary greatly. Facilities can hold multiple certificates in support of their testing programs; clinics, patient floors, operating rooms, emergency rooms, etc.

Tests often used at the Point of Care TEST SYSTEM WAIVED NONWAIVED Cholesterol Screens Capillary finger-stick Capillary finger-stick Blood Glucose- whole blood Reagent strip meters Portable bench top analyzers Pregnancy (hcg) Pregnancy tests- Urine Pregnancy tests- Serum Prothrombin time (PT) Home use/professional use Hand held analyzers Respiratory viruses Nasopharyngeal swabs Nasopharyngeal swabs Streptococcus group A Throat swabs Throat swabs Urinalysis Dip-stick methods Microscopic urine exam Urine Drug Screen Multi-panel drug screen Multi-panel drug screen

Percent of Laboratories CMS -Waived Laboratory Growth Laboratories by Certificate Type 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% Non-exempt Laboratories by Application Type 0% 1993 1995 2000 2005 2010 2014 Accreditation 23751 19426 16992 15607 15864 16328 Compliance 44762 37578 25068 20480 19404 18695 Waiver 67294 65031 85944 113445 141994 170404 Year Waiver Compliance Accreditation Year

Certificate of Waiver Project CW labs are increasing exponentially Congress never anticipated this growth Concerns over quality testing arose 1999 Initial Pilot in Colorado and Ohio 2000 Expanded Pilot project to 8 additional States 2002 - Pilot expanded to remaining States

CoW Site Visits Announced, designed to help educate on sound laboratory practices Surveyors determine: Testing being conducted in manner that protects patient safety Regulatory compliance Performing tests appropriate for a CoW laboratory

Good Laboratory Practices for Waived Testing Sites Educational booklet with job aids Poster and postcards

Top Waived Testing Deficiencies

Following Manufacturer s Instructions Wording found in package inserts can be above reading level/comprehension of nonlaboratory staff Package inserts can be printed with small fonts and not have standardized formats between manufacturer s

Manufacturer s Instructions con t Staff not following established instructions (taking shortcuts or ) use the picture diagram to perform the test. Testing restrictions and limitations noted in the package insert may be missed.

Documentation/Records Results not documented as required by manufacturer (ex. + rather than positive or Pos ) Not having most current package insert available Testing Kit expiration dates were not changed if stored at room temperature

Quality Control(QC) Quality control was not performed if required by manufacturer (ex. frequency of QC) QC performed but not documented as required or not documented (ex. Internal control interpretation failure)

Challenges in POCT

Challenges: POCT Testing Programs Providers want tests results quickly so look at waived testing to fill the need More and more testing being manufactured & introduced to the market are done at point-of-care with non-laboratory staff Personnel unknowingly use laboratory tests in a manner not clinically validated by the manufacturer (off-label use).

Modification or off-label A test system modification of a waived or moderate complexity test system means any 1. change in intended use, 2. adjustments to the precautions, limitations 3. changes to manufacturer s instructions that could affect test system performance specifications for; sensitivity, specificity, accuracy and precision.

Test Modification allows for modification of waived or moderate complexity tests. If providers decide to modify a waived or moderate test, the test is classified as high complexity All high complexity test regulations will apply

Regulatory Impact for Providers Obtain the appropriate certificate High complexity personnel requirements are met The laboratory must establish performance specifications in order to ensure the accuracy and reliability of the test results after the modification of the test system is made.

Performance Specifications accuracy precision reference range reportable range analytic sensitivity analytic specificity 493.1253(b)(2)

Review POCT Programs Examine the test menu in the POCT program(s) Confirm the test complexity of each test Verify that the facility has the correct type of certificate Look closely at the manufacturer s instructions And if test modifications are chosen, that they be performed in compliance with, State or AO requirements.

Lab Excellence Mailbox Questions? LabExcellence@cms.hhs.gov

Resources: Website CDC: Ready, Set, Test http://www.cdc.gov/dls/waivedtests